Table 1. Demographic and Clinical Characteristics of the Sample.
| OCD group (n=34) | Control group (n=34) | |
|---|---|---|
| Agea | 40.9±12.38 | 40.41±10.26 |
| Gender | 15 Male | 16 Male |
| 19 Female | 18 Female | |
| Mean illness duration | 16.65±8.48 | NA |
| Y-BOCS scores currenta | 24.34±6.32 | NA |
| Y-BOCS lifetimea | 24.43±8.25 | NA |
| BDI scores currenta | 22.75±13.85 | NA |
| Medications (# of subjects, mean dose in mg) | Sertraline (1, 100) Citalopram (2, 140) Quetiapine (3, 217) Venlafaxine (5, 390) Trazodone (1, 100) Gabapentine (2, 2100) Topiramate (1, 50) Methylphenidate (1, 80) Paroxetine (4, 70) Lorazepam (2, 1) Fluvoxamine (1, 160) Fluoxetine (1, 20) Tryptophan (1, 4000) Pimozide (1, 3) | NA |
Abbreviations: BDI, beck depression inventory; OCD, obsessive compulsive disorder; Y-BOCS, Yale-Brown Obsessive Compulsive Scale.
a
Data reported as mean±SD.